Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420108 · ClinicalTrials.gov registry record
Optivol Diagnostic Data for Discharge in Heart Failure
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 23
- Enrollment target
NCT00420108: Completed study, sponsored by Thomas Jefferson University.
NCT00420108 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00420108 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate whether the heart rate variability, daily heart rate, and/or intrathoracic impedance recorded by implantable cardiac devices can be used in conjunction with other traditional clinical practice methods to determine if heart failure patients are ready for hospital discharge.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-02 |
What the finished NCT00420108 record still lists
NCT00420108 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00420108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00420108 about?
NCT00420108 is a clinical study titled "Optivol Diagnostic Data for Discharge in Heart Failure". The objective of this study is to evaluate whether the heart rate variability, daily heart rate, and/or intrathoracic impedance recorded by implantable cardiac devices can be used in conjunction with other traditional clinical practice methods to determine if heart failure patients are ready for hos...
What is the current status of trial NCT00420108?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2006-12. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00420108?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia